SynthesisBMC urology2025
The incidence and risk factors of urinary tract infections in patients undergoing bladder tumor resection: a systematic review and meta-analysis.
Synthesis in BMC urology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Unconventional T cells in urological cancers: catch them if you can.Nature reviews. Urology · 2026Review
- Development and internal validation of a clinical prediction model for postoperative urinary tract infection in older surgical patients: a retrospective cohort study.BMC geriatrics · 2026Article
- Urinary tract infection caused by rare yeastFrontiers in immunology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
aimTo summarise the available evidence concerning the incidence and risk factors of UTIs in bladder cancer patients after surgery.
methodsSystematic searches were conducted on PubMed, Embase, Web of Science, Cochrane Library, CINAHL, the China National Knowledge Base Database (CNKI), Wanfang Database, Vips Database (VIP), and the China Biomedical Database (Sinomed). These searches encompassed literature from the inception of each database up to March 2025. This study adhered rigorously to the PRISMA guidelines. The quality of the studies included in the review was assessed using the Joanna Briggs Institute (JBI) Centre for Evidence-Based Health Care in Australia and the Newcastle-Ottawa Scale.
resultsA total of 19 original studies were included in this analysis, encompassing 5,905 patients. The meta-analysis results indicated that the incidence of UTIs in patients with bladder tumor resection was 22.3% [95% CI (17.7, 27.3)]. The identified risk factors for UTIs in patients with bladder cancer after surgery include diabetes, age, preoperative catheter indwelling, Use of antibiotics before surgery, and Operation time≥90 min.
conclusionsUTIs are higher in patients who have undergone bladder tumor resection. Clinical staff should prioritize preoperative assessment and risk stratification for UTIs. They must adhere to established guidelines and recommendations regarding the prophylactic use of antibiotics before surgery, maintain strict control of patients' blood sugar levels, and manage catheters meticulously to minimize the risk of UTIs.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.